Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours.

Ong CJ, Tan QX, Lim HJ, Shannon NB, Lim WK, Hendrikson J, Ng WH, Tan JWS, Koh KKN, Wasudevan SD, Ng CCY, Rajasegaran V, Lim TKH, Ong CK, Kon OL, Teh BT, Tan GHC, Chia CS, Soo KC, Teo MCC.

Sci Rep. 2020 Jan 20;10(1):682. doi: 10.1038/s41598-019-55146-2.

PMID:
31959771
2.

Strategies to Overcome Residual Risk During Statins Era.

Cho KI, Yu J, Hayashi T, Han SH, Koh KK.

Circ J. 2019 Sep 25;83(10):1973-1979. doi: 10.1253/circj.CJ-19-0624. Epub 2019 Aug 6.

3.

Impact of Longitudinal Changes in Metabolic Syndrome Status over 2 Years on 10-Year Incident Diabetes Mellitus.

Huh JH, Ahn SG, Kim YI, Go T, Sung KC, Choi JH, Koh KK, Kim JY.

Diabetes Metab J. 2019 Aug;43(4):530-538. doi: 10.4093/dmj.2018.0111. Epub 2019 Feb 20.

4.

Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application.

Han SH, Koh KK.

Circ J. 2019 Mar 25;83(4):713-714. doi: 10.1253/circj.CJ-19-0112. Epub 2019 Feb 28. No abstract available.

5.
6.

Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? - An Asian Perspective.

Ihm SH, Bakris G, Sakuma I, Sohn IS, Koh KK.

Circ J. 2019 Feb 25;83(3):504-510. doi: 10.1253/circj.CJ-18-1293. Epub 2018 Dec 29.

7.
10.
11.

Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.

Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK.

Atherosclerosis. 2018 Oct;277:60-65. doi: 10.1016/j.atherosclerosis.2018.08.029. Epub 2018 Aug 25. Review.

PMID:
30173080
12.

Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018).

Huh JH, Kang DR, Jang JY, Shin JH, Kim JY, Choi S, Cho EJ, Park JS, Sohn IS, Jo SH, Sung KC, Koh KK.

Atherosclerosis. 2018 Oct;277:47-52. doi: 10.1016/j.atherosclerosis.2018.08.003. Epub 2018 Aug 17.

PMID:
30172084
14.

Letter by Koh Regarding Article, "J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm".

Koh KK.

Circulation. 2018 Jun 5;137(23):2547-2548. doi: 10.1161/CIRCULATIONAHA.117.033172. No abstract available.

PMID:
29866784
16.

Letter by Koh Regarding Article, "Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study".

Koh KK.

Circulation. 2018 May 15;137(20):2195-2196. doi: 10.1161/CIRCULATIONAHA.117.031070. No abstract available.

PMID:
29760235
17.

Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.

Lim S, Eckel RH, Koh KK.

Atherosclerosis. 2018 May;272:33-40. doi: 10.1016/j.atherosclerosis.2018.03.013. Epub 2018 Mar 8. Review.

PMID:
29547706
18.

Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits.

Cho KI, Sakuma I, Sohn IS, Hayashi T, Shimada K, Koh KK.

Circ J. 2018 Mar 23;82(4):937-943. doi: 10.1253/circj.CJ-17-1445. Epub 2018 Mar 2. Review.

21.

A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT).

Koh KK, Nam CW, Chao TH, Liu ME, Wu CJ, Kim DS, Kim CJ, Li I, Li J, Baccara-Dinet MT, Hsiao PJ, Chiang CE.

J Clin Lipidol. 2018 Jan - Feb;12(1):162-172.e6. doi: 10.1016/j.jacl.2017.09.007. Epub 2017 Oct 19.

22.

A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer.

Ong CJ, Shannon NB, Mueller S, Lek SM, Qiu X, Chong FT, Li K, Koh KKN, Tay GCA, Skanthakumar T, Hwang JSG, Hon Lim TK, Ang MK, Tan DSW, Tan NC, Tan HK, Soo KC, Iyer NG.

Oncotarget. 2017 Jun 19;8(45):79556-79566. doi: 10.18632/oncotarget.18568. eCollection 2017 Oct 3.

23.

Letter by Koh Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".

Koh KK.

Circulation. 2017 Oct 24;136(17):1668-1669. doi: 10.1161/CIRCULATIONAHA.117.029815. No abstract available.

PMID:
29061580
25.

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ.

Korean Circ J. 2017 Jul;47(4):432-439. doi: 10.4070/kcj.2016.0406. Epub 2017 Jul 26. Review.

26.

Letter by Koh Regarding Article, "Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism".

Koh KK.

Circulation. 2017 Jul 4;136(1):118-119. doi: 10.1161/CIRCULATIONAHA.117.027744. No abstract available.

PMID:
28674099
27.

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.

Koh KK.

N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361. No abstract available.

PMID:
28471635
28.

Letter by Koh Regarding Article, "Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?"

Koh KK.

Circulation. 2017 Apr 25;135(17):e1006-e1007. doi: 10.1161/CIRCULATIONAHA.116.026821. No abstract available.

PMID:
28438812
29.

Laboratory tests on heat treatment of ballast water using engine waste heat.

Balaji R, Lee Siang H, Yaakob O, Koh KK, Adnan FAB, Ismail NB, Ahmad BB, Ismail MAB, Wan Nik WB.

Environ Technol. 2018 May;39(9):1102-1114. doi: 10.1080/09593330.2017.1321691. Epub 2017 May 7.

PMID:
28425309
30.

Cost Effectiveness of Nonstatin-to-Statin Therapy.

Koh KK.

J Am Coll Cardiol. 2017 Apr 18;69(15):1995. doi: 10.1016/j.jacc.2016.12.045. No abstract available.

31.

Age estimation from structural changes of teeth and buccal alveolar bone level.

Koh KK, Tan JS, Nambiar P, Ibrahim N, Mutalik S, Khan Asif M.

J Forensic Leg Med. 2017 May;48:15-21. doi: 10.1016/j.jflm.2017.03.004. Epub 2017 Apr 1.

PMID:
28407514
33.

Role of Adiponectin: Important or Null?

Koh KK.

J Am Coll Cardiol. 2017 Mar 21;69(11):1518. doi: 10.1016/j.jacc.2016.10.093. No abstract available.

34.

Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.

Park J, Kim JS, Kim SH, Kim S, Lim SY, Lim HE, Cho GY, Sung KC, Kim JY, Baik I, Koh KK, Lee JB, Lee SK, Shin C.

Cardiovasc Diabetol. 2017 Mar 14;16(1):36. doi: 10.1186/s12933-017-0519-5.

35.

What Is the Best Disease-Guided Approach to Statin?

Koh KK.

J Am Coll Cardiol. 2017 Feb 7;69(5):600. doi: 10.1016/j.jacc.2016.11.035. No abstract available.

36.
37.

Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk.

Yang YJ, Lee SH, Kim BS, Cho YK, Cho HJ, Cho KI, Kim SY, Ryu JK, Cho JM, Park JI, Park JS, Park CG, Chun WJ, Kim MA, Jin DK, Lee N, Kim BJ, Koh KK, Suh J, Lee SH, Lee BK, Oh SJ, Jin HY, Ahn Y, Lee SG, Bae JH, Park WJ, Lee SC, Lee HC, Lee J, Park C, Lee B, Jang Y.

Clin Ther. 2017 Jan;39(1):107-117. doi: 10.1016/j.clinthera.2016.11.014. Epub 2016 Dec 19.

PMID:
28007331
38.
39.

Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".

Koh KK.

Circulation. 2016 Sep 27;134(13):e294-5. doi: 10.1161/CIRCULATIONAHA.116.023680. No abstract available.

PMID:
27672200
40.

Rosuvastatin dose-dependently improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients.

Koh KK, Oh PC, Sakuma I, Lee Y, Han SH, Shin EK.

Int J Cardiol. 2016 Nov 15;223:488-493. doi: 10.1016/j.ijcard.2016.08.051. Epub 2016 Aug 8.

PMID:
27544612
41.

Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia.

Koh KK, Oh PC, Sakuma I, Lee Y, Han SH, Shin EK.

Int J Cardiol. 2016 Oct 15;221:342-6. doi: 10.1016/j.ijcard.2016.07.038. Epub 2016 Jul 5.

PMID:
27424313
42.

Calming down chaos regarding redefining blood pressure targets-the importance of statin-based therapy.

Koh KK, Han SH, Sakuma I, Zhao D.

Int J Cardiol. 2016 Oct 15;221:572-4. doi: 10.1016/j.ijcard.2016.06.121. Epub 2016 Jun 23. No abstract available.

PMID:
27420580
43.

Acute ischemic stroke mimicking acute coronary syndrome.

Lee JS, Oh PC, Koh KK.

Int J Cardiol. 2016 Oct 15;221:560-1. doi: 10.1016/j.ijcard.2016.06.114. Epub 2016 Jun 23. No abstract available.

PMID:
27420577
44.

Recurrent stress-induced cardiomyopathy presented with acute decompensated heart failure.

Oh PC, Koh KK.

Int J Cardiol. 2016 Jun 1;212:307-9. doi: 10.1016/j.ijcard.2016.03.126. Epub 2016 Mar 24. No abstract available.

PMID:
27057947
45.

Hypertriglyceridemia and Cardiovascular Diseases: Revisited.

Han SH, Nicholls SJ, Sakuma I, Zhao D, Koh KK.

Korean Circ J. 2016 Mar;46(2):135-44. doi: 10.4070/kcj.2016.46.2.135. Epub 2016 Mar 21. Review.

46.

Angiotensin converting enzyme inhibitors remain the first treatment of choice.

Oh PC, Sakuma I, Hayashi T, Koh KK.

Korean J Intern Med. 2016 Mar;31(2):237-41. doi: 10.3904/kjim.2016.026. Epub 2016 Feb 26. No abstract available.

47.

Intriguing Off-Target Effects of Ezetimibe.

Koh KK.

J Am Coll Cardiol. 2015 Dec 22;66(24):2808. doi: 10.1016/j.jacc.2015.08.1130. No abstract available.

48.

Obesity and cardiovascular disease: friend or foe?

Kim SH, Després JP, Koh KK.

Eur Heart J. 2016 Dec 21;37(48):3560-3568. doi: 10.1093/eurheartj/ehv509. Epub 2015 Dec 18. Review.

PMID:
26685971
49.

How to Control Residual Risk During the Statin Era?

Koh KK.

J Am Coll Cardiol. 2015 Oct 20;66(16):1848. doi: 10.1016/j.jacc.2015.07.072. No abstract available.

50.

Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf.

Koh KK, Oh PC, Sakuma I.

Int J Cardiol. 2016 Jan 1;202:154-5. doi: 10.1016/j.ijcard.2015.08.163. Epub 2015 Aug 25. No abstract available.

PMID:
26397402

Supplemental Content

Support Center